---
title: Fujifilm Pharmaceuticals U.S.A., Inc vs National Resilience
slug_a: fujifilmpharma
slug_b: resilience
site: cdmo
review_signal_gate: closed
canonical_path: /compare/fujifilmpharma/resilience
---

# Fujifilm Pharmaceuticals U.S.A., Inc vs National Resilience

Side-by-side profile data from each company listing on this directory.

## Fujifilm Pharmaceuticals U.S.A., Inc

- Profile: [/companies/fujifilmpharma](/companies/fujifilmpharma)

Fujifilm Pharmaceuticals U.S.A., Inc — CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.

Services: 9. Modalities: 2. Indications: 2. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Upstream Processing
- Downstream Processing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- Quality Control Testing

### Modalities

- Oligonucleotide
- mRNA

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials

## National Resilience

- Profile: [/companies/resilience](/companies/resilience)

National Resilience — End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.

Services: 21. Modalities: 6. Indications: 0. Locations: 5. Certifications: 5. The strongest documented coverage currently appears in services (21).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Upstream Processing
- Downstream Processing
- Bioconjugation Services
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Secondary Packaging & Labeling

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Cell Therapy
- Gene Therapy
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Prefilled Syringes (PFS)
- Cartridges
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Microbial
- Single-Use / Disposable